Fierce Medical Affairs Strategic Summit 2024

HOWARD L. DORFMAN is an Adjunct Professor and Distinguished Practitioner in Residence at Seton Hall Law School where he has taught courses on FDA Regulations, Health Law and Healthcare Compliance and is Founder of H.L. Dorfman Pharmaceutical Consulting, LLC, which provides FDA regulatory... Read More →

Pranav Abraham leads Medical Evidence Strategy for Sanofi's Global Medical Affairs Rare Diseases team. He has deep expertise in using digital health technologies to capture patient outcomes, develop novel endpoints, and leverage healthcare data for generating innovative real-world... Read More →

Christine is the Co-Founder and Chief Executive Officer of Evidation. Previously, Christine was the Co-Founder and Chief Operating Officer of Sense Networks, developers of the first machine learning platform for mobile phone activity data (exited to YP.com). She has also held roles... Read More →

Felix has over 20 years in strategy and innovation building new business offerings, partnerships, investments, products and services, inside and outside healthcare, across geographies, functions and contexts.  He currently heads the medical development of digital healthcare for Sanofi... Read More →

Michael J. Doane is a Senior Director and Head of Health Economics and Outcomes Research (HEOR) at Alkermes, Inc. Joining Alkermes, Inc. in 2018, Michael’s expertise includes the collection, analysis, and communication of patient-centric data to quantify disease burden and identify... Read More →

Kimberly Barnholt, Ph.D., has been a healthcare leader in various roles spanning from academic research, to disruptive start-up, to global pharmaceutical company. In all roles, she has focused on bridging science, data, and operational disciplines to challenge the status quo and transform... Read More →